C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric

Dan Turner1, David R Mack, Jeffrey Hyams

  • 1Pediatric Gastroenterology and Nutrition Unit, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel. turnerd@szmc.org.il

Journal of Crohn'S & Colitis
|September 24, 2011
PubMed

Insights

In pediatric ulcerative colitis (UC), both C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can monitor disease activity. While CRP shows a slight superiority and better correlation with endoscopic findings, routine testing of both may not be necessary.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Chemistry
  • Inflammatory Bowel Disease Research

Background:

  • Limited comparative studies exist on C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) for monitoring ulcerative colitis (UC) activity.
  • Understanding the utility of these biomarkers is crucial for effective pediatric UC management.

Purpose of the Study:

  • To extensively compare the diagnostic and monitoring utility of CRP and ESR in pediatric patients with ulcerative colitis (UC).
  • To determine the correlation of CRP and ESR with endoscopic disease activity and clinical assessments.

Main Methods:

  • Analysis of laboratory, clinical, and endoscopic data from 451 children with UC across four cohorts.
  • Longitudinal analysis of prospectively collected data from 75 children.
  • Disease activity assessed using global assessment and the pediatric UC activity index (PUCAI).

Main Results:

  • Optimal thresholds for differentiating UC disease activity were established for both ESR and CRP.
  • CRP demonstrated a stronger correlation with endoscopic appearance (0.55) compared to ESR (0.41).
  • Discordant results between CRP and ESR were observed in a significant proportion of patients across different disease activity levels.

Conclusions:

  • Both CRP and ESR reflect disease activity similarly in approximately two-thirds of pediatric UC patients.
  • CRP may offer a slight advantage and is more closely linked to endoscopic findings.
  • Routine testing of both CRP and ESR for monitoring UC disease activity may not be consistently justified.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...